The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at ...
Abortion medication access, like mifepristone, is unchanged under Trump, but FDA reviews, lawsuits and state enforcement are creating risks for drugmakers.
Two state lawmakers are sparring over how to enshrine protections in state law for women who have miscarriages or other ...
Marjorie Dannenfelser called for FDA Commissioner Marty Makary to be fired for allegedly delaying a mifepristone safety ...
Maine Gov. Janet Mills, known for advancing abortion rights, receives a key endorsement for her 2026 Senate bid against incumbent Susan Collins.
The ballot measure also includes a ban on gender affirming health care for minors. Judges reissued the summary statement that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results